Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

No. 4: Aoxing Pharmaceuticals ( AXN)

I have a confession to make: I know nothing about Aoxing Pharmaceuticals. While researching this story, I tried to find something that would explain why the Chinese drug maker performed so poorly this year. My best guess is that U.S. investors have no interest in owning a money-losing drug company that operates halfway around the world. This year's implosion of so many Chinese reverse-merger stocks probably didn't help Aoxing much either.

The stock: Aoxing is down 91% this year.

If you liked this article you might like

Alimera (ALIM) Is Today's Strong On High Volume Stock

Weak On High Volume: Alimera (ALIM)

Insider Trading Alert - VLGEA, LLTC And ALIM Traded By Insiders

5 Stocks Insiders Love Right Now

5 Stocks Under $10 Set to Soar